Scientific Council

Nicole Dale

Why Precision Alone Isn't Enough in Oncology Drug Discovery

Precision alone isn’t enough in oncology drug discovery. See why execution, biomarkers, and trial design determine scalable success in precision medicine.

Nicole Dale

Phenotypic Drug Discovery: Beyond the Target

Phenotypic drug discovery is reshaping how pharma finds first-in-class drugs. This analysis covers the methods, AI integration, and strategic decisions R&D leaders face in 2026.

Nicole Dale

Strategic Pharma Intelligence Drives Better Decisions in Life Sciences

Strategic pharma intelligence concept featuring Pharmatica branding, molecular structures, global business leaders in discussion, and pharmaceutical innovation imagery, representing data-driven decision-making, industry analysis, and executive strategy in the life sciences sector.

Find out why strategic pharma intelligence is needed to connect insights and to guide confident decision-making across the drug development lifecycle.

Nicole Dale

Why the U.S. Medicine Supply Chain Is One Shortage Away from Crisis

The USP's 2025 Vulnerable Medicines List flags 100 drugs at high risk. Here is what to do to build pharma supply chain resilience.

Nicole Dale

Seven Ways AI Is Solving Pharmaceutical Supply Chain Problems

AI is tackling the pharmaceutical supply chain's most persistent problems, from demand forecasting to counterfeit detection. See the top 7 ways AI is improving supply chain resiliency.

Nicole Dale

The Looming Threat of Geopolitical Risk in Clinical Supply Chains

Geopolitical risk is reshaping how clinical supply chains are managed, demanding resilience and foresight. Learn why building supply chain resilience is the key for clinical trial success.